Who
Noel Donnelly
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, PepGen.
In numbers
- Trades disclosed
- 23
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $29K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 6 May 2022
- Last trade
- 4 Mar 2026
- Last filed
- 6 Mar 2026
Companies traded
Activity over time
1 Feb 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Mar 2026filed 6 Mar 2026 | PEPG PepGenBiotechnology | SEC FORM 4 Sold | $13K2,032 at $6.23 | filing |
| 4 Mar 2026filed 6 Mar 2026 | PEPG PepGenBiotechnology | SEC FORM 4 Sold | $32952 at $6.33 | filing |
| 4 Mar 2026filed 6 Mar 2026 | PEPG PepGenBiotechnology | SEC FORM 4 Sold | $13K2,032 at $6.23 | filing |
| 4 Mar 2026filed 6 Mar 2026 | PEPG PepGenBiotechnology | SEC FORM 4 Sold | $32952 at $6.33 | filing |
| 1 Mar 2026filed 2 Mar 2026 | PEPG PepGenBiotechnology | SEC FORM 4 Code A | —76,793 at $0.00 | filing |
| 1 Mar 2026filed 2 Mar 2026 | PEPG PepGenoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 1 Mar 2026filed 2 Mar 2026 | PEPG PepGenoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 1 Mar 2026filed 2 Mar 2026 | PEPG PepGenBiotechnology | SEC FORM 4 Code A | —76,793 at $0.00 | filing |
| 4 Nov 2025filed 18 Dec 2025 | PEPG PepGenoption or derivative · Biotechnology | SEC FORM 4 Code D | —203,339 at $0.00 | filing |
| 4 Nov 2025filed 18 Dec 2025 | PEPG PepGenoption or derivative · Biotechnology | SEC FORM 4 Code A | —203,339 at $0.00 | filing |
| 4 Nov 2025filed 18 Dec 2025 | PEPG PepGenoption or derivative · Biotechnology | SEC FORM 4 Code D | —169,037 at $0.00 | filing |
| 4 Nov 2025filed 18 Dec 2025 | PEPG PepGenoption or derivative · Biotechnology | SEC FORM 4 Code A | —169,037 at $0.00 | filing |
| 4 Nov 2025filed 18 Dec 2025 | PEPG PepGenoption or derivative · Biotechnology | SEC FORM 4 Code D | —144,000 at $0.00 | filing |
| 4 Nov 2025filed 18 Dec 2025 | PEPG PepGenoption or derivative · Biotechnology | SEC FORM 4 Code A | —144,000 at $0.00 | filing |
| 4 Nov 2025filed 18 Dec 2025 | PEPG PepGenoption or derivative · Biotechnology | SEC FORM 4 Code D | —144,000 at $0.00 | filing |
| 4 Nov 2025filed 18 Dec 2025 | PEPG PepGenoption or derivative · Biotechnology | SEC FORM 4 Code A | —144,000 at $0.00 | filing |
| 3 Mar 2025filed 5 Mar 2025 | PEPG PepGenoption or derivative · Biotechnology | SEC FORM 4 Code A | —104,250 at $0.00 | filing |
| 3 Mar 2025filed 5 Mar 2025 | PEPG PepGenBiotechnology | SEC FORM 4 Code A | —23,283 at $0.00 | filing |
| 26 Feb 2025filed 26 Feb 2025 | PEPG PepGenBiotechnology | SEC FORM 4 Sold | $2,5651,527 at $1.68 | filing |
| 24 Feb 2025filed 26 Feb 2025 | PEPG PepGenBiotechnology | SEC FORM 4 Code A | —3,200 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.